首页 > 最新文献

Israel Journal of Health Policy Research最新文献

英文 中文
Use and barriers to the use of telehealth services in the Arab population in Israel: a cross sectional survey. 以色列阿拉伯人口使用远程保健服务的情况和障碍:一项横断面调查。
IF 4.5 4区 医学 Q1 Medicine Pub Date : 2023-05-23 DOI: 10.1186/s13584-023-00569-6
Nadav Penn, Michal Laron

Background: Studies conducted in Israel and in other countries show that minority populations typically underuse telehealth services notwithstanding the advantages inherent in the use of these services. The goal of this study was to examine telehealth use patterns and the barriers to the use of telehealth services in the Arab population in Israel, which is a culturally and ethnically varied minority population with a unique language and culture.

Methods: A telephone survey was conducted among a representative sample of the adult Arab population in Israel from October 29 to November 4, 2020. Of the randomly sampled 1,192 adult Israeli Arabs 501 participants responded to the entire questionnaire, representing a response rate of 42%.

Results: The study found that the majority of the adult Arab population in Israel faced no technology or Internet accessibility barriers. Thus, the majority of adult Israeli Arabs (87%) use the Internet on a daily basis and have smartphones (96%) and an Internet connection (93%). However, although they have high technology and Internet accessibility, their use of telehealth services is mostly a telephone appointment with a doctor (66%). At the same time, significantly lower use rates were found with regard to advanced telehealth services delivered through the Internet, e.g., consultation with a health care provider by email or chat (34%) or video chat (8%) and ordering of medications (14%). It was found that Arab Christians are more likely to use digital services than Arab Muslims, even when background characteristics are statistically controlled. Lack of awareness was found to be the major barrier to the use of telehealth services, specifically advanced services such as ordering of medications (23%) and video medical consultation (15%). A high rate of women cited the unmet need for the discreet provision of telehealth services as a barrier to their use of the services. It was also found that the majority of the adult Arab population had no objection in principle to the use of email or chat (75%) or video chat (51%) for consultation with a health care provider. It was further found that facilitating factors promoting the use of telehealth services include previous acquaintance with the health care provider, a stable internet infrastructure, the provision of the services in the Arabis language, guidance in the use of the service, a recommendation by a health care provider, and the participation of a family member in the online medical consultation.

Conclusions: The study findings highlight the need for the provision of accessible and customized telehealth services for minority populations. Whether delivered over the phone or through the Internet, the services have to be culturally (for Muslims and Christians) and linguistically (Arabic) adapted, guidance in the use of the services should be provided, and service marketing should be t

背景:在以色列和其他国家进行的研究表明,尽管使用远程保健服务具有固有的优势,但少数民族人口通常未充分利用这些服务。本研究的目的是审查以色列阿拉伯人口使用远程保健的模式和使用远程保健服务的障碍,这是一个文化和种族多样化的少数民族人口,拥有独特的语言和文化。方法:于2020年10月29日至11月4日对以色列成年阿拉伯人口的代表性样本进行电话调查。在随机抽样的1192名成年以色列阿拉伯人中,有501人回答了整个问卷,回复率为42%。结果:研究发现,以色列的大多数成年阿拉伯人没有技术或互联网接入障碍。因此,大多数成年以色列阿拉伯人(87%)每天都使用互联网,拥有智能手机(96%)和互联网连接(93%)。然而,尽管他们拥有高科技和互联网接入,但他们使用远程保健服务的方式主要是通过电话预约医生(66%)。与此同时,通过互联网提供的先进远程保健服务的使用率明显较低,例如,通过电子邮件或聊天(34%)或视频聊天(8%)向保健提供者咨询以及订购药物(14%)。研究发现,阿拉伯基督徒比阿拉伯穆斯林更有可能使用数字服务,即使背景特征在统计上受到控制。调查发现,缺乏认识是使用远程保健服务的主要障碍,特别是订购药物(23%)和视频医疗咨询(15%)等高级服务。很高比例的妇女指出,对谨慎提供远程保健服务的需求未得到满足,这是她们使用这些服务的一个障碍。调查还发现,大多数阿拉伯成年人口原则上不反对使用电子邮件或聊天(75%)或视频聊天(51%)向保健提供者咨询。进一步发现,促进使用远程保健服务的便利因素包括:以前熟悉保健提供者、稳定的互联网基础设施、以阿拉伯语提供服务、使用服务的指导、保健提供者的建议以及家庭成员参与在线医疗咨询。结论:研究结果强调需要为少数民族人口提供可获取和定制的远程保健服务。无论是通过电话还是通过互联网提供,这些服务都必须适应文化(针对穆斯林和基督徒)和语言(阿拉伯语),应提供使用服务的指导,并应针对目标少数民族人口进行服务营销。应制定具体的解决办法,谨慎地向妇女提供远程保健服务,在与保健提供者进行在线咨询时保护她们的隐私,同时应明确指出让家庭成员参与在线医疗咨询的选择。此外,应通过在文化上适应阿拉伯社会的宣传活动,例如通过家庭医生的建议,提高对远程保健服务的认识。
{"title":"Use and barriers to the use of telehealth services in the Arab population in Israel: a cross sectional survey.","authors":"Nadav Penn,&nbsp;Michal Laron","doi":"10.1186/s13584-023-00569-6","DOIUrl":"https://doi.org/10.1186/s13584-023-00569-6","url":null,"abstract":"<p><strong>Background: </strong>Studies conducted in Israel and in other countries show that minority populations typically underuse telehealth services notwithstanding the advantages inherent in the use of these services. The goal of this study was to examine telehealth use patterns and the barriers to the use of telehealth services in the Arab population in Israel, which is a culturally and ethnically varied minority population with a unique language and culture.</p><p><strong>Methods: </strong>A telephone survey was conducted among a representative sample of the adult Arab population in Israel from October 29 to November 4, 2020. Of the randomly sampled 1,192 adult Israeli Arabs 501 participants responded to the entire questionnaire, representing a response rate of 42%.</p><p><strong>Results: </strong>The study found that the majority of the adult Arab population in Israel faced no technology or Internet accessibility barriers. Thus, the majority of adult Israeli Arabs (87%) use the Internet on a daily basis and have smartphones (96%) and an Internet connection (93%). However, although they have high technology and Internet accessibility, their use of telehealth services is mostly a telephone appointment with a doctor (66%). At the same time, significantly lower use rates were found with regard to advanced telehealth services delivered through the Internet, e.g., consultation with a health care provider by email or chat (34%) or video chat (8%) and ordering of medications (14%). It was found that Arab Christians are more likely to use digital services than Arab Muslims, even when background characteristics are statistically controlled. Lack of awareness was found to be the major barrier to the use of telehealth services, specifically advanced services such as ordering of medications (23%) and video medical consultation (15%). A high rate of women cited the unmet need for the discreet provision of telehealth services as a barrier to their use of the services. It was also found that the majority of the adult Arab population had no objection in principle to the use of email or chat (75%) or video chat (51%) for consultation with a health care provider. It was further found that facilitating factors promoting the use of telehealth services include previous acquaintance with the health care provider, a stable internet infrastructure, the provision of the services in the Arabis language, guidance in the use of the service, a recommendation by a health care provider, and the participation of a family member in the online medical consultation.</p><p><strong>Conclusions: </strong>The study findings highlight the need for the provision of accessible and customized telehealth services for minority populations. Whether delivered over the phone or through the Internet, the services have to be culturally (for Muslims and Christians) and linguistically (Arabic) adapted, guidance in the use of the services should be provided, and service marketing should be t","PeriodicalId":46694,"journal":{"name":"Israel Journal of Health Policy Research","volume":null,"pages":null},"PeriodicalIF":4.5,"publicationDate":"2023-05-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10204005/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9610820","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A call to readjust the Israeli school feeding program. 呼吁重新调整以色列学校供餐计划。
IF 4.5 4区 医学 Q1 Medicine Pub Date : 2023-05-10 DOI: 10.1186/s13584-023-00568-7
Dorit Nitzan

The COVID-19 pandemic challenged the food and nutrition security status of thousands of children in Israel. This commentary argues that policymakers should urgently readjust the Israeli school feeding program based on experts' advice. Children should have the right to select food items, grow the items, prepare the meals, and clean and care for the waste together. They should eat as a community in suitable school dining rooms. Access to the school feeding program should also be ensured during emergencies, school closures, isolation and quarantine, treatment, and rehabilitation of children. The food provided through the program should be integrated into the food baskets of their families, aimed at improving their households' food and nutrition security. It is important to activate a universal school feeding program that does not differentiate, separate, and stigmatize children, their households, their communities, and their schools. The United States National School Lunch Program is briefly reviewed, highlighting the importance of the program's routine monitoring, evaluation, and improvement. Engaging the children in planning the meals and in the production, preparedness, provision, and waste management processes are key to improving their involvement, health literacy and promotion, and their families' resilience. Implementing a holistic Food System Approach, including school gardening and "Farm to School," is suggested. It is recommended to urgently formulate a modern, universal, and comprehensive Israeli Food and Nutrition Security Plan, with a dedicated chapter for the upgraded School Feeding Programe with a section on its implementation in emergency preparedness, response, and Resilience. It should be anchored in the Food Systems framework and the One Health Approach.

COVID-19 大流行对以色列成千上万儿童的食品和营养安全状况提出了挑战。本评论认为,政策制定者应根据专家建议紧急调整以色列学校供餐计划。儿童应有权选择食品、种植食品、准备饭菜,并共同清理和处理垃圾。他们应在合适的学校餐厅集体用餐。在紧急情况、学校关闭、隔离检疫、治疗和儿童康复期间,也应确保学校供餐计划的实施。学校供餐计划提供的食物应纳入儿童家庭的菜篮子,以改善其家庭的粮食和营养安全状况。重要的是,要启动一项不对儿童、其家庭、社区和学校进行区分、隔离和污名化的普及学校供餐计划。本文简要回顾了美国全国学校午餐计划,强调了该计划日常监测、评估和改进的重要性。让儿童参与膳食规划以及生产、准备、供应和废物管理过程,是提高他们的参与度、健康知识普及和促进以及家庭复原力的关键。建议实施全面的食品系统方法,包括学校园艺和 "农场到学校"。建议紧急制定一项现代、普遍和全面的《以色列粮食和营养安全计划》,其中专门有一章论述升级后的 "学校供餐计划",并有一节论述该计划在应急准备、响应和复原力方面的实施情况。该计划应立足于粮食系统框架和 "一个健康 "方法。
{"title":"A call to readjust the Israeli school feeding program.","authors":"Dorit Nitzan","doi":"10.1186/s13584-023-00568-7","DOIUrl":"10.1186/s13584-023-00568-7","url":null,"abstract":"<p><p>The COVID-19 pandemic challenged the food and nutrition security status of thousands of children in Israel. This commentary argues that policymakers should urgently readjust the Israeli school feeding program based on experts' advice. Children should have the right to select food items, grow the items, prepare the meals, and clean and care for the waste together. They should eat as a community in suitable school dining rooms. Access to the school feeding program should also be ensured during emergencies, school closures, isolation and quarantine, treatment, and rehabilitation of children. The food provided through the program should be integrated into the food baskets of their families, aimed at improving their households' food and nutrition security. It is important to activate a universal school feeding program that does not differentiate, separate, and stigmatize children, their households, their communities, and their schools. The United States National School Lunch Program is briefly reviewed, highlighting the importance of the program's routine monitoring, evaluation, and improvement. Engaging the children in planning the meals and in the production, preparedness, provision, and waste management processes are key to improving their involvement, health literacy and promotion, and their families' resilience. Implementing a holistic Food System Approach, including school gardening and \"Farm to School,\" is suggested. It is recommended to urgently formulate a modern, universal, and comprehensive Israeli Food and Nutrition Security Plan, with a dedicated chapter for the upgraded School Feeding Programe with a section on its implementation in emergency preparedness, response, and Resilience. It should be anchored in the Food Systems framework and the One Health Approach.</p>","PeriodicalId":46694,"journal":{"name":"Israel Journal of Health Policy Research","volume":null,"pages":null},"PeriodicalIF":4.5,"publicationDate":"2023-05-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171145/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9528916","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Perspective: lessons learned from the COVID-19 pandemic concerning the resilience of the population. 观点:从2019冠状病毒病大流行中吸取的关于人口复原力的教训。
IF 4.5 4区 医学 Q1 Medicine Pub Date : 2023-05-02 DOI: 10.1186/s13584-023-00557-w
Bruria Adini, Shaul Kimhi

Background: A vital stakeholder in the successful management of the COVID-19 pandemic is the public. The degree of involvement of the population in managing the pandemic, and the leadership perception of the public, had a direct impact on the resilience of the population and level of adherence to the issued protective measures.

Main body: Resilience refers to the ability to 'bounce back' or 'bounce forward' following adversity. Resilience facilitates community engagement which is a crucial component of combating the COVID-19 pandemic. The article highlights six insights recognized in studies conducted in Israel during and following the pandemic concerning the resilience of the country's population. (1) Contrary to varied adversities in which the community serves as an important support system to the individuals, this type of support was substantially impaired during the COVID-19 pandemic, due to the need to maintain isolation, social distancing, and lockdowns. (2) Policy-making during the pandemic should be based on evidence-based data, rather than on assumptions made by decision-makers. This gap led the authorities during the pandemic to adopt measures that were ineffective, such as risk communication based on 'scare tactics' concerning the virus, when the highest risk perceived by the public was political instability. (3) Societal resilience is associated with the public's behavior, such as with vaccine hesitancy and uptake. (4) Factors that affect the levels of resilience include, among others, self-efficacy (impacts individual resilience); social, institutional, and economic aspects as well as well-being (impact community resilience); and hope and trust in the leadership (impact societal resilience). (5) The public should be perceived as an asset in managing the pandemic, thus becoming a vital part of the 'solution'. This will lead to a better understanding of the needs and expectations of the population and an applicable 'tailoring' of the messages that address the public. (6) The gap between science and policymaking must be bridged, to achieve optimal management of the pandemic.

Conclusions: Improving preparedness for future pandemics should be based on a holistic view of all stakeholders, including the public as a valued partner, connectivity between policymakers and scientists, and strengthening the public's resilience, by enhancing trust in authorities.

背景:公众是成功管理COVID-19大流行的重要利益攸关方。民众参与管理大流行病的程度,以及领导人对公众的看法,对民众的复原力和遵守已颁布的保护措施的程度有直接影响。正文:弹性是指在逆境中“反弹”或“反弹”的能力。韧性促进社区参与,这是抗击COVID-19大流行的关键组成部分。这篇文章强调了在大流行期间和之后在以色列进行的有关该国人口复原力的研究中所确认的六项见解。(1)在各种逆境中,社区都是个人的重要支持系统,但在2019冠状病毒病大流行期间,由于需要保持隔离、保持社交距离和封锁,这种支持严重受损。(2)大流行期间的决策应基于循证数据,而不是决策者的假设。这一差距导致当局在大流行期间采取了无效的措施,例如在公众认为的最大风险是政治不稳定的情况下,基于“恐吓战术”的风险通报。(3)社会恢复力与公众行为有关,如疫苗犹豫和接种。(4)影响心理弹性水平的因素包括自我效能感(影响个体心理弹性);社会、制度和经济方面以及福祉(影响社区复原力);以及对领导层的希望和信任(影响社会恢复力)。(5)应将公众视为管理大流行的资产,从而成为“解决方案”的重要组成部分。这将有助于更好地了解人口的需要和期望,并对面向公众的信息进行适用的“量身定制”。(6)必须弥合科学与决策之间的差距,以实现对大流行的最佳管理。结论:加强对未来大流行的防范应基于对所有利益攸关方的整体看法,包括作为重要伙伴的公众、决策者和科学家之间的联系,以及通过增强对当局的信任来增强公众的抵御能力。
{"title":"Perspective: lessons learned from the COVID-19 pandemic concerning the resilience of the population.","authors":"Bruria Adini,&nbsp;Shaul Kimhi","doi":"10.1186/s13584-023-00557-w","DOIUrl":"https://doi.org/10.1186/s13584-023-00557-w","url":null,"abstract":"<p><strong>Background: </strong>A vital stakeholder in the successful management of the COVID-19 pandemic is the public. The degree of involvement of the population in managing the pandemic, and the leadership perception of the public, had a direct impact on the resilience of the population and level of adherence to the issued protective measures.</p><p><strong>Main body: </strong>Resilience refers to the ability to 'bounce back' or 'bounce forward' following adversity. Resilience facilitates community engagement which is a crucial component of combating the COVID-19 pandemic. The article highlights six insights recognized in studies conducted in Israel during and following the pandemic concerning the resilience of the country's population. (1) Contrary to varied adversities in which the community serves as an important support system to the individuals, this type of support was substantially impaired during the COVID-19 pandemic, due to the need to maintain isolation, social distancing, and lockdowns. (2) Policy-making during the pandemic should be based on evidence-based data, rather than on assumptions made by decision-makers. This gap led the authorities during the pandemic to adopt measures that were ineffective, such as risk communication based on 'scare tactics' concerning the virus, when the highest risk perceived by the public was political instability. (3) Societal resilience is associated with the public's behavior, such as with vaccine hesitancy and uptake. (4) Factors that affect the levels of resilience include, among others, self-efficacy (impacts individual resilience); social, institutional, and economic aspects as well as well-being (impact community resilience); and hope and trust in the leadership (impact societal resilience). (5) The public should be perceived as an asset in managing the pandemic, thus becoming a vital part of the 'solution'. This will lead to a better understanding of the needs and expectations of the population and an applicable 'tailoring' of the messages that address the public. (6) The gap between science and policymaking must be bridged, to achieve optimal management of the pandemic.</p><p><strong>Conclusions: </strong>Improving preparedness for future pandemics should be based on a holistic view of all stakeholders, including the public as a valued partner, connectivity between policymakers and scientists, and strengthening the public's resilience, by enhancing trust in authorities.</p>","PeriodicalId":46694,"journal":{"name":"Israel Journal of Health Policy Research","volume":null,"pages":null},"PeriodicalIF":4.5,"publicationDate":"2023-05-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10153045/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9467588","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Antimicrobial resistance in food-producing animals: towards implementing a one health based national action plan in Israel. 食品生产动物的抗菌素耐药性:在以色列实施基于一个健康的国家行动计划。
IF 4.5 4区 医学 Q1 Medicine Pub Date : 2023-04-26 DOI: 10.1186/s13584-023-00562-z
Tali Sarah Berman, Zohar Barnett-Itzhaki, Tamar Berman, Eli Marom

Background: Development of antimicrobial resistance poses a major threat to human and animal health worldwide. Antimicrobials are frequently used in animal husbandry, making food-producing animals a widespread and important source of antimicrobial resistance. Indeed, recent evidence demonstrates that antimicrobial resistance in food-producing animals poses a threat to the health of humans, animals and the environment. To address this threat, national action plans have been implemented based on a 'One Health' approach, which integrates actions across human and animal health sectors to combat antimicrobial resistance. Although under development, Israel has yet to publish a national action plan against antimicrobial resistance, despite alarming findings of resistant bacteria in food-producing animals in the country. Here we review several national action plans against antimicrobial resistance around the world in order to suggest approaches to develop a national action plan in Israel.

Main body: We investigated worldwide national action plans against antimicrobial resistance based on a 'One Health' approach. We also conducted interviews with representatives of relevant Israeli ministries to understand antimicrobial resistance policy and regulatory frameworks in Israel. Finally, we present recommendations for Israel towards implementing a 'One Health' national action plan against antimicrobial resistance. Many countries have developed such plans, however, only a few are currently funded. Furthermore, many countries, especially in Europe, have taken action to reduce the use of antimicrobials and the spread of antimicrobial resistance in food-producing animals by banning the use of antimicrobials to promote growth, reporting data on the use and sales of antimicrobials in food-producing animals, operating centralized antimicrobial resistance surveillance systems and preventing the use of antimicrobials important to human medicine to treat food-producing animals.

Conclusions: Without a comprehensive and funded national action plan, the risks of antimicrobial resistance to the public health in Israel will escalate. Thus, several actions should be considered: (1) Reporting data on the use of antimicrobials in humans and animals. (2) Operating a centralized surveillance system for antimicrobial resistance in humans, animals and the environment. (3) Improving awareness regarding antimicrobial resistance in the general public and in health practitioners from both human and animal sectors. (4) Composing a list of critically important antimicrobials to human medicine that's use should be avoided in food-producing animals. (5) Enforcing best practices of antimicrobial use at the farm-level. (6) Reducing incidence of infection through farm biosecurity. (7) Supporting research and development of new antimicrobial treatments, vaccines and diagnostic tools.

背景:抗菌素耐药性的发展对全世界人类和动物健康构成重大威胁。抗菌素经常用于畜牧业,使食用动物成为抗菌素耐药性的广泛和重要来源。事实上,最近的证据表明,食用动物的抗微生物药物耐药性对人类、动物和环境的健康构成威胁。为了应对这一威胁,已根据“同一个卫生”方法实施了国家行动计划,该方法将人类和动物卫生部门的行动结合起来,以对抗抗微生物药物耐药性。尽管正在制定中,但以色列尚未公布一项针对抗菌素耐药性的国家行动计划,尽管该国在食品生产动物中发现了令人震惊的耐药细菌。在这里,我们回顾了世界各地针对抗菌素耐药性的几个国家行动计划,以便提出在以色列制定国家行动计划的方法。主体:我们调查了基于“同一个健康”方针的世界各国抗微生物药物耐药性行动计划。我们还与以色列相关部委的代表进行了访谈,以了解以色列的抗微生物药物耐药性政策和监管框架。最后,我们提出了以色列实施“同一个健康”国家抗微生物药物耐药性行动计划的建议。许多国家已经制定了这样的计划,然而,目前只有少数国家得到资助。此外,许多国家,特别是欧洲国家,已采取行动,通过禁止使用抗菌素促进生长、报告抗菌素在食用动物中的使用和销售数据、运行集中的抗菌素耐药性监测系统和防止使用对人类医学至关重要的抗菌素来治疗食用动物,减少抗菌素耐药性的使用和在食用动物中传播。结论:如果没有一个全面和有资金支持的国家行动计划,以色列抗菌素耐药性对公共卫生的风险将会升级。因此,应考虑采取以下几项行动:(1)报告人类和动物使用抗微生物药物的数据。(2)建立人、动物和环境抗菌素耐药性集中监测系统。(3)提高公众以及人类和动物卫生从业人员对抗菌素耐药性的认识。(4)列出应避免在食用动物中使用的对人类药物至关重要的抗菌素清单。(5)在农场一级执行抗菌药物使用的最佳做法。(6)通过农场生物安全降低感染发生率。(7)支持研究和开发新的抗微生物疗法、疫苗和诊断工具。
{"title":"Antimicrobial resistance in food-producing animals: towards implementing a one health based national action plan in Israel.","authors":"Tali Sarah Berman,&nbsp;Zohar Barnett-Itzhaki,&nbsp;Tamar Berman,&nbsp;Eli Marom","doi":"10.1186/s13584-023-00562-z","DOIUrl":"https://doi.org/10.1186/s13584-023-00562-z","url":null,"abstract":"<p><strong>Background: </strong>Development of antimicrobial resistance poses a major threat to human and animal health worldwide. Antimicrobials are frequently used in animal husbandry, making food-producing animals a widespread and important source of antimicrobial resistance. Indeed, recent evidence demonstrates that antimicrobial resistance in food-producing animals poses a threat to the health of humans, animals and the environment. To address this threat, national action plans have been implemented based on a 'One Health' approach, which integrates actions across human and animal health sectors to combat antimicrobial resistance. Although under development, Israel has yet to publish a national action plan against antimicrobial resistance, despite alarming findings of resistant bacteria in food-producing animals in the country. Here we review several national action plans against antimicrobial resistance around the world in order to suggest approaches to develop a national action plan in Israel.</p><p><strong>Main body: </strong>We investigated worldwide national action plans against antimicrobial resistance based on a 'One Health' approach. We also conducted interviews with representatives of relevant Israeli ministries to understand antimicrobial resistance policy and regulatory frameworks in Israel. Finally, we present recommendations for Israel towards implementing a 'One Health' national action plan against antimicrobial resistance. Many countries have developed such plans, however, only a few are currently funded. Furthermore, many countries, especially in Europe, have taken action to reduce the use of antimicrobials and the spread of antimicrobial resistance in food-producing animals by banning the use of antimicrobials to promote growth, reporting data on the use and sales of antimicrobials in food-producing animals, operating centralized antimicrobial resistance surveillance systems and preventing the use of antimicrobials important to human medicine to treat food-producing animals.</p><p><strong>Conclusions: </strong>Without a comprehensive and funded national action plan, the risks of antimicrobial resistance to the public health in Israel will escalate. Thus, several actions should be considered: (1) Reporting data on the use of antimicrobials in humans and animals. (2) Operating a centralized surveillance system for antimicrobial resistance in humans, animals and the environment. (3) Improving awareness regarding antimicrobial resistance in the general public and in health practitioners from both human and animal sectors. (4) Composing a list of critically important antimicrobials to human medicine that's use should be avoided in food-producing animals. (5) Enforcing best practices of antimicrobial use at the farm-level. (6) Reducing incidence of infection through farm biosecurity. (7) Supporting research and development of new antimicrobial treatments, vaccines and diagnostic tools.</p>","PeriodicalId":46694,"journal":{"name":"Israel Journal of Health Policy Research","volume":null,"pages":null},"PeriodicalIF":4.5,"publicationDate":"2023-04-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10132406/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9828066","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Cytomegalovirus (CMV) seroprevalence among women at childbearing age, maternal and congenital CMV infection: policy implications of a descriptive, retrospective, community-based study. 育龄妇女巨细胞病毒(CMV)血清阳性率、孕产妇和先天性巨细胞病毒感染:一项描述性、回顾性、基于社区的研究对政策的影响。
IF 3.5 4区 医学 Q1 HEALTH POLICY & SERVICES Pub Date : 2023-04-25 DOI: 10.1186/s13584-023-00566-9
Assaf Ben Shoham, Yechiel Schlesinger, Ian Miskin, Ziva Kalderon, Rachel Michaelson-Cohen, Yonit Wiener-Well

Background: Maternal CMV infection during pregnancy, either primary or non-primary, may be associated with fetal infection and long-term sequelae. While guidelines recommend against it, screening for CMV in pregnant women is a prevalent clinical practice in Israel. Our aim is to provide updated, local, clinically relevant, epidemiological information about CMV seroprevalence among women at childbearing age, the incidence of maternal CMV infection during pregnancy and the prevalence of congenital CMV (cCMV), as well as to provide information about the yield of CMV serology testing.

Methods: We performed a descriptive, retrospective study of women at childbearing age who were members of Clalit Health Services in the district of Jerusalem and had at least one gestation during the study period (2013-2019). We utilized serial serology tests to determine CMV serostatus at baseline and at pre/periconception and identified temporal changes in CMV serostatus. We then conducted a sub-sample analysis integrating inpatient data on newborns of women who gave birth in a single large medical center. cCMV was defined as either positive urine CMV-PCR test in a sample collected during the first 3 weeks of life, neonatal diagnosis of cCMV in the medical records, or prescription of valganciclovir during the neonatal period.

Results: The study population Included 45,634 women with 84,110 associated gestational events. Initial CMV serostatus was positive in 89% women, with variation across different ethno-socioeconomic subgroups. Based on consecutive serology tests, the detected incidence rate of CMV infection was 2/1000 women follow-up years, among initially seropositive women, and 80/1000 women follow-up years, among initially seronegative women. CMV infection in pregnancy was identified among 0.2% of women who were seropositive at pre/periconception and among 10% of women who were seronegative. In a subsample, which included 31,191 associated gestational events, we identified 54 newborns with cCMV (1.9/1000 live births). The prevalence of cCMV among newborns of women who were seropositive at pre/periconception was lower than among newborns of women who were seronegative (2.1 vs. 7.1/1000). Frequent serology tests among women who were seronegative at pre/periconception detected most primary CMV infections in pregnancy that resulted in cCMV (21/24). However, among women who were seropositive, serology tests prior to birth detected none of the non-primary infections that resulted in cCMV (0/30).

Conclusions: In this retrospective community-based study among women of childbearing age characterized by multiparity and high seroprevalence of CMV, we find that consecutive CMV serology testing enabled to detect most primary CMV infections in pregnancy that led to cCMV in newborns but failed to detect non-primary CMV infections in pregnancy. Conducting CMV serology tests among seropositi

背景:妊娠期母体 CMV 感染(无论是原发性还是非原发性)可能与胎儿感染和长期后遗症有关。虽然指导原则建议不要对孕妇进行 CMV 筛查,但这在以色列的临床实践中非常普遍。我们的目的是提供有关育龄妇女中 CMV 血清流行率、孕期母体 CMV 感染率和先天性 CMV(cCMV)流行率的最新本地临床流行病学信息,并提供有关 CMV 血清学检测结果的信息:我们对耶路撒冷地区 Clalit 卫生服务机构的育龄妇女进行了一项描述性回顾研究,这些妇女在研究期间(2013-2019 年)至少有过一次妊娠。我们利用序列血清学测试来确定基线和孕前/围产期的 CMV 血清状态,并确定 CMV 血清状态的时间变化。cCMV 的定义是:出生后 3 周内采集的尿液样本中 CMV-PCR 检测呈阳性、病历中新生儿诊断为 cCMV 或新生儿期开具了缬更昔洛韦处方:研究对象包括 45,634 名妇女和 84,110 例相关妊娠事件。89%的妇女最初的 CMV 血清呈阳性,不同种族-社会经济亚群之间存在差异。根据连续的血清学检测,在最初血清呈阳性的妇女中,CMV 感染的检测发病率为 2/1000,在最初血清呈阴性的妇女中,CMV 感染的检测发病率为 80/1000。在孕前/围产期血清反应呈阳性的妇女中,有 0.2%的人在怀孕期间感染了 CMV,而在血清反应呈阴性的妇女中,有 10%的人在怀孕期间感染了 CMV。在包括 31 191 例相关妊娠事件的子样本中,我们发现 54 名新生儿感染了巨细胞病毒(1.9/1000 例活产)。孕前/围产期血清反应阳性妇女的新生儿中 cCMV 感染率低于血清反应阴性妇女的新生儿(2.1 对 7.1/1000)。在孕前/围产期血清学检测呈阴性的妇女中,通过频繁的血清学检测发现了大多数导致 cCMV 的妊娠期原发性 CMV 感染(21/24)。然而,在血清反应呈阳性的妇女中,分娩前的血清检测没有发现导致 cCMV 的非原发性感染(0/30):在这项以社区为基础的回顾性研究中,我们发现在多胎妊娠和 CMV 血清高流行率的育龄妇女中,连续的 CMV 血清学检测能够发现大多数导致新生儿患上 cCMV 的妊娠期原发性 CMV 感染,但未能发现妊娠期非原发性 CMV 感染。尽管有指南建议,但在血清反应阳性的妇女中进行 CMV 血清学检测并没有临床价值,而且成本高昂,还会带来更多的不确定性和困扰。因此,我们建议不要对之前血清学检测呈阳性的妇女进行常规 CMV 血清学检测。我们建议仅在已知血清阴性或血清状态不明的妇女怀孕前进行 CMV 血清学检测。
{"title":"Cytomegalovirus (CMV) seroprevalence among women at childbearing age, maternal and congenital CMV infection: policy implications of a descriptive, retrospective, community-based study.","authors":"Assaf Ben Shoham, Yechiel Schlesinger, Ian Miskin, Ziva Kalderon, Rachel Michaelson-Cohen, Yonit Wiener-Well","doi":"10.1186/s13584-023-00566-9","DOIUrl":"10.1186/s13584-023-00566-9","url":null,"abstract":"<p><strong>Background: </strong>Maternal CMV infection during pregnancy, either primary or non-primary, may be associated with fetal infection and long-term sequelae. While guidelines recommend against it, screening for CMV in pregnant women is a prevalent clinical practice in Israel. Our aim is to provide updated, local, clinically relevant, epidemiological information about CMV seroprevalence among women at childbearing age, the incidence of maternal CMV infection during pregnancy and the prevalence of congenital CMV (cCMV), as well as to provide information about the yield of CMV serology testing.</p><p><strong>Methods: </strong>We performed a descriptive, retrospective study of women at childbearing age who were members of Clalit Health Services in the district of Jerusalem and had at least one gestation during the study period (2013-2019). We utilized serial serology tests to determine CMV serostatus at baseline and at pre/periconception and identified temporal changes in CMV serostatus. We then conducted a sub-sample analysis integrating inpatient data on newborns of women who gave birth in a single large medical center. cCMV was defined as either positive urine CMV-PCR test in a sample collected during the first 3 weeks of life, neonatal diagnosis of cCMV in the medical records, or prescription of valganciclovir during the neonatal period.</p><p><strong>Results: </strong>The study population Included 45,634 women with 84,110 associated gestational events. Initial CMV serostatus was positive in 89% women, with variation across different ethno-socioeconomic subgroups. Based on consecutive serology tests, the detected incidence rate of CMV infection was 2/1000 women follow-up years, among initially seropositive women, and 80/1000 women follow-up years, among initially seronegative women. CMV infection in pregnancy was identified among 0.2% of women who were seropositive at pre/periconception and among 10% of women who were seronegative. In a subsample, which included 31,191 associated gestational events, we identified 54 newborns with cCMV (1.9/1000 live births). The prevalence of cCMV among newborns of women who were seropositive at pre/periconception was lower than among newborns of women who were seronegative (2.1 vs. 7.1/1000). Frequent serology tests among women who were seronegative at pre/periconception detected most primary CMV infections in pregnancy that resulted in cCMV (21/24). However, among women who were seropositive, serology tests prior to birth detected none of the non-primary infections that resulted in cCMV (0/30).</p><p><strong>Conclusions: </strong>In this retrospective community-based study among women of childbearing age characterized by multiparity and high seroprevalence of CMV, we find that consecutive CMV serology testing enabled to detect most primary CMV infections in pregnancy that led to cCMV in newborns but failed to detect non-primary CMV infections in pregnancy. Conducting CMV serology tests among seropositi","PeriodicalId":46694,"journal":{"name":"Israel Journal of Health Policy Research","volume":null,"pages":null},"PeriodicalIF":3.5,"publicationDate":"2023-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10131385/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9573078","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The COVID-19 Israeli tapestry: the intersectionality health equity challenge. 2019冠状病毒病以色列挂毯:交叉卫生公平挑战。
IF 4.5 4区 医学 Q1 Medicine Pub Date : 2023-04-25 DOI: 10.1186/s13584-023-00567-8
Efrat Shadmi, Mohammad Khatib, Sivan Spitzer

Background: COVID-19 is disproportionately affecting disadvantaged populations, with greater representation and worse outcomes in low socioeconomic and minority populations, and in persons from marginalized groups. General health care system approaches to inequity reduction (i.e., the minimization of differences in health and health care which are considered unfair or unjust), address the major social determinants of health, such as low income, ethnic affiliation or remote place of residents. Yet, to effectively reduce inequity there is a need for a multifactorial consideration of the aspects that intersect and generate significant barriers to effective care that can address the unique situations that people face due to their gender, ethnicity and socioeconomic situation.

Main body: To address the health equity challenges of diverse population groups in Israel, we propose to adopt an intersectional approach, allowing to better identify the needs and then better tailor the infection prevention and control modalities to those who need them the most. We focus on the two main ethnic - cultural-religious minority groups, that of Arab Palestinian citizens of Israel and Jewish ultra-orthodox (Haredi) communities. Additionally, we address the unique needs of persons with severe mental illness who often experience an intersection of clinical and sociodemographic risks.

Conclusions: This perspective highlights the need for responses to COVID-19, and future pandemic or global disasters, that adopt the unique lens of intersectionality and equity. This requires that the government and health system create multiple messages, interventions and policies which ensure a person and community tailored approach to meet the needs of persons from diverse linguistic, ethnic, religious, socioeconomic and cultural backgrounds. Under-investment in intersectional responses will lead to widening of gaps and a disproportionate disease and mortality burden on societies' most vulnerable groups.

背景:2019冠状病毒病对弱势群体的影响尤为严重,社会经济地位低的人群和少数群体以及边缘群体的代表性更大,结果也更糟。减少不公平现象的一般卫生保健系统方法(即,尽量减少被认为不公平或不公正的卫生和卫生保健方面的差异),处理卫生的主要社会决定因素,如低收入、种族关系或居民的偏远地区。然而,为了有效减少不平等,需要多因素地考虑相互交叉并对有效护理产生重大障碍的各个方面,这些方面可以解决人们因其性别、种族和社会经济状况而面临的独特情况。主体:为了应对以色列不同人口群体的卫生公平挑战,我们建议采取交叉方法,以便更好地确定需求,然后更好地为最需要的人量身定制感染预防和控制方式。我们关注两个主要的民族-文化-宗教少数群体,即以色列的阿拉伯巴勒斯坦公民和犹太极端正统派(Haredi)社区。此外,我们解决严重精神疾病患者的独特需求,他们经常经历临床和社会人口风险的交叉。结论:这一观点强调,应对COVID-19以及未来的大流行或全球灾害,需要采用独特的交叉性和公平性视角。这就要求政府和卫生系统制定多种信息、干预措施和政策,确保采取适合个人和社区的方法,以满足来自不同语言、种族、宗教、社会经济和文化背景的人的需求。对交叉对策的投资不足将导致差距扩大,并对社会中最脆弱群体造成不成比例的疾病和死亡率负担。
{"title":"The COVID-19 Israeli tapestry: the intersectionality health equity challenge.","authors":"Efrat Shadmi,&nbsp;Mohammad Khatib,&nbsp;Sivan Spitzer","doi":"10.1186/s13584-023-00567-8","DOIUrl":"https://doi.org/10.1186/s13584-023-00567-8","url":null,"abstract":"<p><strong>Background: </strong>COVID-19 is disproportionately affecting disadvantaged populations, with greater representation and worse outcomes in low socioeconomic and minority populations, and in persons from marginalized groups. General health care system approaches to inequity reduction (i.e., the minimization of differences in health and health care which are considered unfair or unjust), address the major social determinants of health, such as low income, ethnic affiliation or remote place of residents. Yet, to effectively reduce inequity there is a need for a multifactorial consideration of the aspects that intersect and generate significant barriers to effective care that can address the unique situations that people face due to their gender, ethnicity and socioeconomic situation.</p><p><strong>Main body: </strong>To address the health equity challenges of diverse population groups in Israel, we propose to adopt an intersectional approach, allowing to better identify the needs and then better tailor the infection prevention and control modalities to those who need them the most. We focus on the two main ethnic - cultural-religious minority groups, that of Arab Palestinian citizens of Israel and Jewish ultra-orthodox (Haredi) communities. Additionally, we address the unique needs of persons with severe mental illness who often experience an intersection of clinical and sociodemographic risks.</p><p><strong>Conclusions: </strong>This perspective highlights the need for responses to COVID-19, and future pandemic or global disasters, that adopt the unique lens of intersectionality and equity. This requires that the government and health system create multiple messages, interventions and policies which ensure a person and community tailored approach to meet the needs of persons from diverse linguistic, ethnic, religious, socioeconomic and cultural backgrounds. Under-investment in intersectional responses will lead to widening of gaps and a disproportionate disease and mortality burden on societies' most vulnerable groups.</p>","PeriodicalId":46694,"journal":{"name":"Israel Journal of Health Policy Research","volume":null,"pages":null},"PeriodicalIF":4.5,"publicationDate":"2023-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10129307/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9467133","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Understanding and addressing populations whose prior experience has led to mistrust in healthcare. 了解和解决那些先前经历导致对医疗保健不信任的人群。
IF 4.5 4区 医学 Q1 Medicine Pub Date : 2023-04-21 DOI: 10.1186/s13584-023-00565-w
Dan Even, Shifra Shvarts

Background: Policy makers need to maintain public trust in healthcare systems in order to foster citizen engagement in recommended behaviors and treatments. The importance of such commitment has been highlighted by the recent COVID-19 pandemic. Central to public trust is the extent of the accountability of health authorities held responsible for long-term effects of past treatments. This paper addresses the topic of manifestations of trust among patients damaged by radiation treatments for ringworm.

Methods: For this mixed-methods case study (quan/qual), we sampled 600 files of Israeli patients submitting claims to the National Center for Compensation of Scalp Ringworm Victims in the years 1995-2014, following damage from radiation treatments received between 1946 and 1960 in Israel and/or abroad. Qualitative data were analyzed with descriptive statistics, and correlations were analyzed with chi-square tests. Verbal data were analyzed by the use of systematic content analysis.

Results: Among 527 patients whose files were included in the final analysis, 42% held authorities responsible. Assigning responsibility to authorities was more prevalent among claimants born in Israel than among those born and treated abroad (χ2 = 6.613, df = 1, p = 0.01), claimants reporting trauma (χ2 = 4.864, df = 1, p = 0.027), and claimants living in central cities compared with those in suburban areas (χ2 = 18.859, df = 6, p < 0.01). Men, younger claimants, patients with a psychiatric diagnosis, and patients from minority populations expressed mistrust in health regulators.

Conclusions: Examining populations' perceived trust in healthcare institutions and tailoring health messages to vulnerable populations can promote public trust in healthcare systems.

背景:决策者需要维持公众对医疗保健系统的信任,以促进公民参与推荐的行为和治疗。最近的COVID-19大流行凸显了这种承诺的重要性。公众信任的核心是对过去治疗的长期影响负责的卫生当局的问责程度。本文讨论了放射治疗损伤的癣患者之间的信任表现。方法:在这个混合方法的案例研究中,我们抽样了1995-2014年期间向国家头皮癣受害者赔偿中心提交索赔的600名以色列患者,这些患者在1946年至1960年期间在以色列和/或国外接受放射治疗造成的损伤。定性资料采用描述性统计分析,相关性采用卡方检验分析。口头资料采用系统的内容分析法进行分析。结果:在纳入最终分析的527例患者中,42%的患者认为当局有责任。在以色列出生的索赔人比在国外出生和治疗的索赔人更普遍地将责任分配给当局(χ2 = 6.613, df = 1, p = 0.01),索赔人报告创伤(χ2 = 4.864, df = 1, p = 0.027),居住在中心城市的索赔人比居住在郊区的索赔人更普遍(χ2 = 18.859, df = 6, p)。检查民众对卫生保健机构的感知信任,并为弱势群体量身定制卫生信息,可以促进公众对卫生保健系统的信任。
{"title":"Understanding and addressing populations whose prior experience has led to mistrust in healthcare.","authors":"Dan Even,&nbsp;Shifra Shvarts","doi":"10.1186/s13584-023-00565-w","DOIUrl":"https://doi.org/10.1186/s13584-023-00565-w","url":null,"abstract":"<p><strong>Background: </strong>Policy makers need to maintain public trust in healthcare systems in order to foster citizen engagement in recommended behaviors and treatments. The importance of such commitment has been highlighted by the recent COVID-19 pandemic. Central to public trust is the extent of the accountability of health authorities held responsible for long-term effects of past treatments. This paper addresses the topic of manifestations of trust among patients damaged by radiation treatments for ringworm.</p><p><strong>Methods: </strong>For this mixed-methods case study (quan/qual), we sampled 600 files of Israeli patients submitting claims to the National Center for Compensation of Scalp Ringworm Victims in the years 1995-2014, following damage from radiation treatments received between 1946 and 1960 in Israel and/or abroad. Qualitative data were analyzed with descriptive statistics, and correlations were analyzed with chi-square tests. Verbal data were analyzed by the use of systematic content analysis.</p><p><strong>Results: </strong>Among 527 patients whose files were included in the final analysis, 42% held authorities responsible. Assigning responsibility to authorities was more prevalent among claimants born in Israel than among those born and treated abroad (χ<sup>2</sup> = 6.613, df = 1, p = 0.01), claimants reporting trauma (χ<sup>2</sup> = 4.864, df = 1, p = 0.027), and claimants living in central cities compared with those in suburban areas (χ<sup>2</sup> = 18.859, df = 6, p < 0.01). Men, younger claimants, patients with a psychiatric diagnosis, and patients from minority populations expressed mistrust in health regulators.</p><p><strong>Conclusions: </strong>Examining populations' perceived trust in healthcare institutions and tailoring health messages to vulnerable populations can promote public trust in healthcare systems.</p>","PeriodicalId":46694,"journal":{"name":"Israel Journal of Health Policy Research","volume":null,"pages":null},"PeriodicalIF":4.5,"publicationDate":"2023-04-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10120492/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9475590","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
A 10-year comparison of short versus long-term court-ordered psychiatric hospitalization: a follow-up study. 一项为期10年的短期与长期法院命令精神病院的比较:一项随访研究。
IF 4.5 4区 医学 Q1 Medicine Pub Date : 2023-04-20 DOI: 10.1186/s13584-023-00561-0
Daniel Argo, Khaled Daibas, Igor Barash, Moshe Z Abramowitz

Background: The Israel Mental Health Act of 1991 stipulates a process for court-ordered involuntary psychiatric hospitalization. As in many Western countries, this process is initiated when an individual is deemed "not criminally responsible by reason of mental disorder (NCR-MD)" or "incompetent to stand trial (IST)." A patient thus hospitalized may be discharged by the district psychiatric committee (DPC). The decision rendered by the DPC is guided by an amendment to the Mental Health Act that states that the length of the hospitalization should be in accordance with the maximum time of incarceration associated with the alleged crime. Little empirical research has been devoted to the psychiatric, medical, and social outcome of short versus long-term hospitalization under court order.

Methods: In our study we examined the outcomes of court-ordered criminal commitments over a 10-year period (2005-2015) at the Jerusalem Mental Health Center with a catchment area of 1.5 million. We found 136 cases (between the ages of 18 and 60) of criminal commitments during that period and used the average length of hospitalization, 205 days, as a cutoff point between short and long stays. We compared the outcomes of short and long hospitalizations of discharged patients using a follow-up phone survey (at least 7 years post-discharge) and data extracted from the Israel National Register to include recidivism, patient satisfaction and trust in the system, readmission, and demise.

Results: We found no statistically significant difference between short-term and long-term hospitalizations for reducing instances of re-hospitalization (p = 0.889) and recidivism (p = 0.54), although there was a slight trend toward short-term hospitalization vis-à-vis reduced recidivism. We did not find a statistical difference in mortality or incidents of suicide between the two groups, but the absolute numbers are higher than expected in both of them. Moreover, our survey showed that short-term hospitalization inspired more trust in the legal process (conduct of the DPC), in pharmacological treatment satisfaction, and in understanding the NCR-MD as a step toward avoiding future hospitalization and that it resulted in a higher level of patient satisfaction.

Conclusions: The results we present show that as far as recidivism and readmission are concerned, there is no evidence to suggest that there is an advantage to long-term hospitalization. Although there may be unmeasured variables not investigated in the present study that might have contributed to the discrepancy between long- and short-term hospitalization, we believe that longer hospitalizations may not serve the intended treatment purpose. Additionally, the high cost of long-term hospitalization and overcrowded wards are obviously major practical drawbacks. The impact of the clinical outcomes should be reflected in medico-legal legislation and

背景:1991年《以色列精神卫生法》规定了法院命令非自愿精神病住院的程序。与许多西方国家一样,当一个人被认为“由于精神障碍(NCR-MD)而不承担刑事责任”或“无法接受审判(IST)”时,就会启动这一程序。因此住院的病人可由区精神病委员会(DPC)批准出院。DPC作出的决定以《精神卫生法》修正案为指导,该修正案规定,住院时间应与与所指控罪行有关的最长监禁时间相一致。很少有实证研究专门针对法院命令下短期与长期住院治疗的精神病学、医学和社会结果。方法:在我们的研究中,我们检查了耶路撒冷心理健康中心(集水区150万)10年间(2005-2015年)法院下令犯罪的结果。我们发现在此期间有136例(年龄在18至60岁之间)犯罪行为,并使用平均住院时间205天作为短期和长期住院的分界点。我们通过随访电话调查(出院后至少7年)比较出院患者短期和长期住院的结果,并从以色列国家登记册中提取数据,包括再犯、患者满意度和对系统的信任、再入院和死亡。结果:我们发现短期和长期住院在减少再次住院(p = 0.889)和再犯(p = 0.54)方面没有统计学上的显著差异,尽管短期住院与-à-vis减少再犯有轻微的趋势。我们没有发现两组在死亡率或自杀事件上有统计学差异,但绝对数字都高于预期。此外,我们的调查显示,短期住院激发了对法律程序(DPC的行为),药理治疗满意度以及将NCR-MD理解为避免未来住院的一步的更多信任,并导致更高水平的患者满意度。结论:我们目前的研究结果表明,就累犯和再入院而言,没有证据表明长期住院有优势。虽然在本研究中可能存在未测量的变量,这些变量可能导致长期和短期住院之间的差异,但我们认为长期住院可能无法达到预期的治疗目的。此外,长期住院费用高和病房过度拥挤显然是主要的实际缺点。临床结果的影响应反映在医疗法律立法中,特别是法院命令的住院治疗中。
{"title":"A 10-year comparison of short versus long-term court-ordered psychiatric hospitalization: a follow-up study.","authors":"Daniel Argo,&nbsp;Khaled Daibas,&nbsp;Igor Barash,&nbsp;Moshe Z Abramowitz","doi":"10.1186/s13584-023-00561-0","DOIUrl":"https://doi.org/10.1186/s13584-023-00561-0","url":null,"abstract":"<p><strong>Background: </strong>The Israel Mental Health Act of 1991 stipulates a process for court-ordered involuntary psychiatric hospitalization. As in many Western countries, this process is initiated when an individual is deemed \"not criminally responsible by reason of mental disorder (NCR-MD)\" or \"incompetent to stand trial (IST).\" A patient thus hospitalized may be discharged by the district psychiatric committee (DPC). The decision rendered by the DPC is guided by an amendment to the Mental Health Act that states that the length of the hospitalization should be in accordance with the maximum time of incarceration associated with the alleged crime. Little empirical research has been devoted to the psychiatric, medical, and social outcome of short versus long-term hospitalization under court order.</p><p><strong>Methods: </strong>In our study we examined the outcomes of court-ordered criminal commitments over a 10-year period (2005-2015) at the Jerusalem Mental Health Center with a catchment area of 1.5 million. We found 136 cases (between the ages of 18 and 60) of criminal commitments during that period and used the average length of hospitalization, 205 days, as a cutoff point between short and long stays. We compared the outcomes of short and long hospitalizations of discharged patients using a follow-up phone survey (at least 7 years post-discharge) and data extracted from the Israel National Register to include recidivism, patient satisfaction and trust in the system, readmission, and demise.</p><p><strong>Results: </strong>We found no statistically significant difference between short-term and long-term hospitalizations for reducing instances of re-hospitalization (p = 0.889) and recidivism (p = 0.54), although there was a slight trend toward short-term hospitalization vis-à-vis reduced recidivism. We did not find a statistical difference in mortality or incidents of suicide between the two groups, but the absolute numbers are higher than expected in both of them. Moreover, our survey showed that short-term hospitalization inspired more trust in the legal process (conduct of the DPC), in pharmacological treatment satisfaction, and in understanding the NCR-MD as a step toward avoiding future hospitalization and that it resulted in a higher level of patient satisfaction.</p><p><strong>Conclusions: </strong>The results we present show that as far as recidivism and readmission are concerned, there is no evidence to suggest that there is an advantage to long-term hospitalization. Although there may be unmeasured variables not investigated in the present study that might have contributed to the discrepancy between long- and short-term hospitalization, we believe that longer hospitalizations may not serve the intended treatment purpose. Additionally, the high cost of long-term hospitalization and overcrowded wards are obviously major practical drawbacks. The impact of the clinical outcomes should be reflected in medico-legal legislation and ","PeriodicalId":46694,"journal":{"name":"Israel Journal of Health Policy Research","volume":null,"pages":null},"PeriodicalIF":4.5,"publicationDate":"2023-04-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10120128/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9474229","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The COVID-19 pandemic posed many dilemmas for policymakers, which sometimes resulted in unprecedented decision-making. 2019冠状病毒病大流行给决策者带来了许多困境,有时导致前所未有的决策。
IF 4.5 4区 医学 Q1 Medicine Pub Date : 2023-04-18 DOI: 10.1186/s13584-023-00564-x
Nachman Ash, Noa Triki, Ruth Waitzberg

Background: The COVID-19 pandemic evolved through five phases, beginning with 'the great threat', then moving through 'the emergence of variants', 'vaccines euphoria', and 'the disillusionment', and culminating in 'a disease we can live with'. Each phase required a different governance response. With the progress of the pandemic, data were collected, evidence was created, and health technology was developed and disseminated. Policymaking shifted from protecting the population by limiting infections with non-pharmaceutical interventions to controlling the pandemic by prevention of severe disease with vaccines and drugs for those infected. Once the vaccine became available, the state started devolving the responsibility for the individual's health and behavior.

Main body: Each phase of the pandemic posed new and unique dilemmas for policymakers, which resulted in unprecedented decision-making. Restrictions to individual's rights such as a lockdown or the 'Green Pass policy' were unimaginable before the pandemic. One of the most striking decisions that the Ministry of Health made was approving the third (booster) vaccine dose in Israel, before it was approved by the FDA or any other country. It was possible to make an informed, evidence-based decision due to the availability of reliable and timely data. Transparent communication with the public probably promoted adherence to the booster dose recommendation. The boosters made an important contribution to public health, even though their uptake was less than the uptake for the initial doses. The decision to approve the booster illustrates seven key lessons from the pandemic: health technology is key; leadership is crucial (both political and professional); a single body should coordinate the actions of all stakeholders involved in the response, and these should collaborate closely; policymakers need to engage the public and win their trust and compliance; data are essential to build a suitable response; and nations and international organizations should collaborate in preparing for and responding to pandemics, because viruses travel without borders.

Conclusion: The COVID-19 pandemic posed many dilemmas for policymakers. The lessons learned from the actions taken to deal with them should be incorporated into preparedness for future challenges.

背景:2019冠状病毒病大流行经历了五个阶段,从“巨大威胁”开始,然后经历了“变种的出现”、“疫苗兴奋”和“幻灭”,最后达到“一种我们可以忍受的疾病”。每个阶段都需要不同的治理响应。随着大流行的进展,收集了数据,创造了证据,开发和传播了卫生技术。政策制定从通过非药物干预措施限制感染来保护人口转向通过为感染者接种疫苗和药物预防严重疾病来控制大流行。一旦有了疫苗,国家就开始下放对个人健康和行为的责任。正文:大流行的每个阶段都给决策者带来了新的和独特的困境,从而导致前所未有的决策。对个人权利的限制,如封锁或“绿色通行证政策”,在大流行之前是不可想象的。卫生部做出的最惊人的决定之一是在FDA或任何其他国家批准之前,在以色列批准了第三剂(加强剂)疫苗。由于有可靠和及时的数据,因此有可能做出知情的、基于证据的决定。与公众的透明沟通可能促进了对加强剂量建议的遵守。增强剂对公众健康做出了重要贡献,尽管它们的吸收比最初剂量的吸收要少。批准加强疫苗的决定说明了大流行的七个关键教训:卫生技术是关键;领导力至关重要(无论是政治上的还是专业上的);一个单一的机构应协调参与应对的所有利益攸关方的行动,这些利益攸关方应密切合作;政策制定者需要让公众参与进来,赢得他们的信任和遵从;数据对于制定适当的应对措施至关重要;各国和国际组织应该合作,为流行病做好准备并作出反应,因为病毒是无国界传播的。结论:新冠肺炎大流行给政策制定者带来了许多困境。应对这些挑战所采取的行动所取得的经验教训应纳入应对未来挑战的准备工作中。
{"title":"The COVID-19 pandemic posed many dilemmas for policymakers, which sometimes resulted in unprecedented decision-making.","authors":"Nachman Ash,&nbsp;Noa Triki,&nbsp;Ruth Waitzberg","doi":"10.1186/s13584-023-00564-x","DOIUrl":"https://doi.org/10.1186/s13584-023-00564-x","url":null,"abstract":"<p><strong>Background: </strong>The COVID-19 pandemic evolved through five phases, beginning with 'the great threat', then moving through 'the emergence of variants', 'vaccines euphoria', and 'the disillusionment', and culminating in 'a disease we can live with'. Each phase required a different governance response. With the progress of the pandemic, data were collected, evidence was created, and health technology was developed and disseminated. Policymaking shifted from protecting the population by limiting infections with non-pharmaceutical interventions to controlling the pandemic by prevention of severe disease with vaccines and drugs for those infected. Once the vaccine became available, the state started devolving the responsibility for the individual's health and behavior.</p><p><strong>Main body: </strong>Each phase of the pandemic posed new and unique dilemmas for policymakers, which resulted in unprecedented decision-making. Restrictions to individual's rights such as a lockdown or the 'Green Pass policy' were unimaginable before the pandemic. One of the most striking decisions that the Ministry of Health made was approving the third (booster) vaccine dose in Israel, before it was approved by the FDA or any other country. It was possible to make an informed, evidence-based decision due to the availability of reliable and timely data. Transparent communication with the public probably promoted adherence to the booster dose recommendation. The boosters made an important contribution to public health, even though their uptake was less than the uptake for the initial doses. The decision to approve the booster illustrates seven key lessons from the pandemic: health technology is key; leadership is crucial (both political and professional); a single body should coordinate the actions of all stakeholders involved in the response, and these should collaborate closely; policymakers need to engage the public and win their trust and compliance; data are essential to build a suitable response; and nations and international organizations should collaborate in preparing for and responding to pandemics, because viruses travel without borders.</p><p><strong>Conclusion: </strong>The COVID-19 pandemic posed many dilemmas for policymakers. The lessons learned from the actions taken to deal with them should be incorporated into preparedness for future challenges.</p>","PeriodicalId":46694,"journal":{"name":"Israel Journal of Health Policy Research","volume":null,"pages":null},"PeriodicalIF":4.5,"publicationDate":"2023-04-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10112313/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9472899","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
"I'm 'just' a community pediatrician" views and challenges of pediatricians working in the community in Israel. “我‘只是’一名社区儿科医生”以色列社区儿科医生的观点和挑战。
IF 4.5 4区 医学 Q1 Medicine Pub Date : 2023-04-17 DOI: 10.1186/s13584-023-00563-y
Shulamit Pinchover, Rony Berger-Raanan, Maya Yaari, Mary Rudolf, Lisa Rubin, Dafna Idan-Prusak, Vera Skvirsky, Tirzah Margolin, Hava Gadassi

Background: There are ongoing changes around the world in the training and practice of pediatricians who work in the community. These changes are driven by the understanding that pediatricians are required to provide not only acute primary care but also to address more comprehensive concerns, particularly the 'new morbidities'. The present study examines the professional identity of Israeli pediatricians in the community in light of these changes, the barriers and challenges to their work and professional adaptations in the field.

Methods: We used a mixed-methods approach, collecting the perspectives of 137 pediatricians who work in the community through an anonymous online survey, followed by in-depth semi-structured interviews with 11 community pediatricians.

Results: The survey results show that community pediatricians in Israel have limited knowledge on a variety of developmental, behavioral and emotional issues; that they lack working relationships with medical or other professionals; and are rarely engaged with other community services. Three main themes arose from the interviews that support and deepen the survey results: perceptions of the profession (pediatrics in the community vs. community pediatrics), the stature of pediatricians in the community (during residency, the choice to work in the community, their daily work) and barriers and change in community pediatrics (isolation, limited resources and challenges arising from the nature of community work).

Conclusions: The present study sheds light on the professional identity and the day-to-day challenges and successes of pediatricians working in the community. Continuing medical education, providing a supportive framework and professional community, better resources, more time with patients, and tools and opportunities for professional development would help pediatricians who work in the community to overcome some of these challenges. The research findings reinforce the need for policy change in the field of community pediatrics with a specific community training curriculum, provision of more resources and ongoing support for pediatricians. This requires partnership between the HMOs, the Ministry of Health, the Scientific Council (Israel Medical Association, professional organizations) and NGOs in order to turn individual-level solutions into system-level and policy-changing solutions.

背景:在世界范围内,在社区工作的儿科医生的培训和实践正在发生变化。这些变化是由于人们认识到儿科医生不仅需要提供急性初级保健,还需要解决更全面的问题,特别是“新发病率”。本研究考察了以色列儿科医生在社区的职业认同,根据这些变化,障碍和挑战,他们的工作和专业适应领域。方法:我们采用混合方法,通过匿名在线调查收集了137名在社区工作的儿科医生的观点,随后对11名社区儿科医生进行了深入的半结构化访谈。结果:调查结果显示,以色列的社区儿科医生对各种发育、行为和情绪问题的了解有限;他们缺乏与医疗或其他专业人士的工作关系;很少参与其他社区服务。从支持和深化调查结果的访谈中产生了三个主要主题:对专业的看法(社区儿科与社区儿科),社区儿科医生的地位(住院期间,在社区工作的选择,他们的日常工作)以及社区儿科的障碍和变化(孤立,资源有限和社区工作性质带来的挑战)。结论:本研究揭示了在社区工作的儿科医生的职业认同、日常挑战和成功。继续医学教育,提供一个支持性的框架和专业社区,更好的资源,更多的时间与病人相处,以及专业发展的工具和机会,将帮助在社区工作的儿科医生克服其中一些挑战。研究结果强调需要在社区儿科领域进行政策改革,制定具体的社区培训课程,提供更多的资源,并为儿科医生提供持续的支持。这需要卫生保健组织、卫生部、科学理事会(以色列医学协会、专业组织)和非政府组织之间的伙伴关系,以便将个人层面的解决方案转化为系统层面和改变政策的解决方案。
{"title":"\"I'm 'just' a community pediatrician\" views and challenges of pediatricians working in the community in Israel.","authors":"Shulamit Pinchover,&nbsp;Rony Berger-Raanan,&nbsp;Maya Yaari,&nbsp;Mary Rudolf,&nbsp;Lisa Rubin,&nbsp;Dafna Idan-Prusak,&nbsp;Vera Skvirsky,&nbsp;Tirzah Margolin,&nbsp;Hava Gadassi","doi":"10.1186/s13584-023-00563-y","DOIUrl":"https://doi.org/10.1186/s13584-023-00563-y","url":null,"abstract":"<p><strong>Background: </strong>There are ongoing changes around the world in the training and practice of pediatricians who work in the community. These changes are driven by the understanding that pediatricians are required to provide not only acute primary care but also to address more comprehensive concerns, particularly the 'new morbidities'. The present study examines the professional identity of Israeli pediatricians in the community in light of these changes, the barriers and challenges to their work and professional adaptations in the field.</p><p><strong>Methods: </strong>We used a mixed-methods approach, collecting the perspectives of 137 pediatricians who work in the community through an anonymous online survey, followed by in-depth semi-structured interviews with 11 community pediatricians.</p><p><strong>Results: </strong>The survey results show that community pediatricians in Israel have limited knowledge on a variety of developmental, behavioral and emotional issues; that they lack working relationships with medical or other professionals; and are rarely engaged with other community services. Three main themes arose from the interviews that support and deepen the survey results: perceptions of the profession (pediatrics in the community vs. community pediatrics), the stature of pediatricians in the community (during residency, the choice to work in the community, their daily work) and barriers and change in community pediatrics (isolation, limited resources and challenges arising from the nature of community work).</p><p><strong>Conclusions: </strong>The present study sheds light on the professional identity and the day-to-day challenges and successes of pediatricians working in the community. Continuing medical education, providing a supportive framework and professional community, better resources, more time with patients, and tools and opportunities for professional development would help pediatricians who work in the community to overcome some of these challenges. The research findings reinforce the need for policy change in the field of community pediatrics with a specific community training curriculum, provision of more resources and ongoing support for pediatricians. This requires partnership between the HMOs, the Ministry of Health, the Scientific Council (Israel Medical Association, professional organizations) and NGOs in order to turn individual-level solutions into system-level and policy-changing solutions.</p>","PeriodicalId":46694,"journal":{"name":"Israel Journal of Health Policy Research","volume":null,"pages":null},"PeriodicalIF":4.5,"publicationDate":"2023-04-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10111851/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9528379","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Israel Journal of Health Policy Research
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1